InvestorsHub Logo

Jesspro

10/23/14 7:29 AM

#55388 RE: LUMA14 #55387

Luma, don't be surprised if one morning there is a news that FDA is reconsidering its use. HB is relentless inthe pursuit for front line. As we speak amidst their silence, they are working for ways and means with the FDA to allow patients to get this treatment. This is how biotech operates.